ATE504284T1 - Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens - Google Patents

Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens

Info

Publication number
ATE504284T1
ATE504284T1 AT03711238T AT03711238T ATE504284T1 AT E504284 T1 ATE504284 T1 AT E504284T1 AT 03711238 T AT03711238 T AT 03711238T AT 03711238 T AT03711238 T AT 03711238T AT E504284 T1 ATE504284 T1 AT E504284T1
Authority
AT
Austria
Prior art keywords
compositions
carrying
exonuclease resistant
labeled oligonucleotides
quencher domain
Prior art date
Application number
AT03711238T
Other languages
English (en)
Inventor
Quin Chou
Cabradilla, Jr
Dragan Spasic
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27753904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE504284(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Priority claimed from PCT/US2003/005641 external-priority patent/WO2003072051A2/en
Application granted granted Critical
Publication of ATE504284T1 publication Critical patent/ATE504284T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6825—Nucleic acid detection involving sensors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT03711238T 2002-02-27 2003-02-25 Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens ATE504284T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/087,229 US6818420B2 (en) 2002-02-27 2002-02-27 Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US10/222,943 US7160997B2 (en) 2002-02-27 2002-08-15 Methods of using FET labeled oligonucleotides that include a 3′→5′ exonuclease resistant quencher domain and compositions for practicing the same
PCT/US2003/005641 WO2003072051A2 (en) 2002-02-27 2003-02-25 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same

Publications (1)

Publication Number Publication Date
ATE504284T1 true ATE504284T1 (de) 2011-04-15

Family

ID=27753904

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08153863T ATE464874T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon
AT03711238T ATE504284T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08153863T ATE464874T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon

Country Status (4)

Country Link
US (7) US6818420B2 (de)
EP (1) EP1952792B2 (de)
AT (2) ATE464874T1 (de)
DE (2) DE60336639D1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019129B1 (en) * 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
JP4481656B2 (ja) * 2002-02-27 2010-06-16 ライフ テクノロジーズ コーポレーション ３’→５’エキソヌクレアーゼ耐性クエンチャードメインを含むｆｅｔ標識オリゴヌクレオチドを使用する方法およびそれを実施するための組成物
US6818420B2 (en) * 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US7365176B2 (en) * 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
US20040235032A1 (en) * 2003-05-19 2004-11-25 Canon Kabushiki Kaisha PCR amplification method, PCR primer set, PCR amplification product, and method for detection of nucleic acid using the amplification method
EP1502958A1 (de) * 2003-08-01 2005-02-02 Roche Diagnostics GmbH Neues Format zur Detektion von Heissstart- und Echtzeit-Polymerasekettenreaktion
BRPI0415771A (pt) 2003-10-23 2006-12-26 Illumigen Biosciences Inc detecção de mutações em um gene associado à resistência a infecção viral, oas1
NZ591879A (en) * 2003-10-23 2012-11-30 Kineta Two Llc Detection of mutations in a gene associated with resistance to viral infection, OAS1
US20050250134A1 (en) * 2004-03-02 2005-11-10 Dawei Sheng Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
EP1740711A2 (de) 2004-04-01 2007-01-10 Bio-Rad Laboratories, Inc. Quantitative amplifikation mit einer markierten sonde und 3' nach 5' exonukleaseaktivität
EP1758895A1 (de) * 2004-06-17 2007-03-07 Wyeth a Corporation of the State of Delaware Gonadotropin-freisetzende hormonrezeptor-antagonisten
BRPI0512239A (pt) * 2004-06-17 2008-02-19 Wyeth Corp processos para preparação de antagonistas de receptores de hormÈnios liberadores de gonatropina
US7635598B2 (en) * 2004-07-08 2009-12-22 Biosearch Technologies, Inc. Inducible fluorescence assay
CA2587853A1 (en) * 2004-11-23 2006-06-01 Wyeth Gonadotropin releasing hormone receptor antagonists
US7534796B2 (en) * 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) * 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
UA95446C2 (ru) * 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Мутаци в генах oas1
US7531542B2 (en) * 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) * 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
WO2007056312A2 (en) * 2005-11-07 2007-05-18 Clontech Laboratories, Inc. Universal reporter tag for nucleozyme assays
WO2008094205A2 (en) * 2006-08-04 2008-08-07 The Board Of Trustees Of The Leland Stanford Junior University A mild chemically cleavable linker system
LT2757091T (lt) * 2008-04-01 2017-09-11 Biosearch Technologies, Inc. Stabilizuotos nukleorūgšties tamsūs kvenčerio-fluoroforo zondai
CA2722940A1 (en) 2008-05-06 2009-11-12 Robert S. Whitehouse Biodegradable polyester blends
US9534255B2 (en) * 2008-12-17 2017-01-03 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
EP3249053A1 (de) 2009-03-27 2017-11-29 Life Technologies Corporation Verfahren, zusammensetzungen und kits für den nachweis von allelen varianten
KR20110050327A (ko) 2009-11-07 2011-05-13 주식회사 씨젠 Ｔｈｄ 프라이머 타겟 검출
US9845492B2 (en) * 2009-12-21 2017-12-19 Seegene, Inc. TSG primer target detection
KR20120042100A (ko) * 2010-10-22 2012-05-03 주식회사 씨젠 이중표지 고정화 프로브를 이용한 고상에서의 타겟 핵산서열 검출
CN104755538B (zh) 2012-08-17 2018-08-31 Cj 第一制糖株式会社 用于聚合物共混物的生物基橡胶改性剂
US10669417B2 (en) 2013-05-30 2020-06-02 Cj Cheiljedang Corporation Recyclate blends
NL2012570B1 (nl) * 2014-04-04 2016-03-08 Sparkle Innovations B V Inrichting en werkwijze voor het druppel-voor-druppel toedienen van een vloeistof.
US9724464B2 (en) * 2014-06-30 2017-08-08 Carefusion 303, Inc. Passive restart Y-site
CN104569599B (zh) * 2015-01-09 2017-10-31 杭州电子科技大学 一种电子标签电阻在线检测电路
US10814006B2 (en) 2015-07-14 2020-10-27 University Of Iowa Research Foundation Fluorescent prodrugs
EP4299763A2 (de) * 2015-09-22 2024-01-03 Biocartis NV Verbesserte detektion von kurzen homopolymeren wiederholungen
US10337051B2 (en) 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
WO2020028729A1 (en) 2018-08-01 2020-02-06 Mammoth Biosciences, Inc. Programmable nuclease compositions and methods of use thereof
EP3841205A4 (de) 2018-08-22 2022-08-17 The Regents of The University of California Crispr/cas-effektor-polypeptide vom variantentyp v und verfahren zur verwendung davon
WO2020046809A1 (en) 2018-08-27 2020-03-05 The Regents Of The University Of California Reporter nucleic acids for type v crispr-mediated detection
EP3931313A2 (de) 2019-01-04 2022-01-05 Mammoth Biosciences, Inc. Verbesserungen an programmierbarer nuklease und zusammensetzungen und verfahren zur nukleinsäureamplifikation und -detektion
EP4219700A1 (de) 2019-03-07 2023-08-02 The Regents of the University of California Crispr-cas-effektorpolypeptide und verfahren zur verwendung davon
US20230235414A1 (en) 2020-05-27 2023-07-27 King Abdullah University Of Science And Technology Iscan: an rt-lamp-coupled crispr-cas module for rapid, sensitive detection of sars-cov-2
EP4388133A2 (de) 2021-08-20 2024-06-26 Kasa Bio, L.L.C. Zusammensetzungen und verfahren für den multiplexnachweis von mirna und anderen polynukleotiden

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8A (en) * 1836-08-10 T Blanchard Machine for cutting scores around ships' tackle blocks and dead eyes
US4743535A (en) 1984-11-07 1988-05-10 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
ATE40572T1 (de) 1985-01-10 1989-02-15 Molecular Diagnostics Inc Photochemisches verfahren zum markieren von nucleinsaeuren zum nachweis in hybridisationsproben.
US4794073A (en) * 1985-07-10 1988-12-27 Molecular Diagnostics, Inc. Detection of nucleic acid hybrids by prolonged chemiluminescence
US5824796A (en) 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
US5763162A (en) * 1990-03-14 1998-06-09 The Regents Of University Of California Multichromophore fluorescent DNA intercalation complexes
US5177196A (en) * 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
KR100236506B1 (ko) * 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
US6329346B1 (en) 1991-05-25 2001-12-11 Roche Diagnostics Gmbh Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
US5419966A (en) 1991-06-10 1995-05-30 Microprobe Corporation Solid support for synthesis of 3'-tailed oligonucleotides
AU645915B2 (en) * 1991-07-23 1994-01-27 F. Hoffmann-La Roche Ag Improvements in the in situ PCR
DE4140463A1 (de) 1991-12-09 1993-06-17 Boehringer Mannheim Gmbh 2'-desoxy-isoguanosin, dessen isostere analoge sowie anwendung derselben
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5840493A (en) * 1994-03-30 1998-11-24 Mitokor Mitochondrial DNA mutations that segregate with late onset diabetes mellitus
US6312894B1 (en) 1995-04-03 2001-11-06 Epoch Pharmaceuticals, Inc. Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
CA2219891C (en) 1995-05-05 2002-01-29 Applied Biosystems, Llc Methods and reagents for combined pcr amplification and hybridization probing assay
EP0937098B1 (de) * 1995-06-07 2002-08-14 Invitrogen Corporation Rekombinatorische klonierung in vitro unter verwendung genmanipulierter rekombinationsorte
US6964861B1 (en) * 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
US5955590A (en) * 1996-07-15 1999-09-21 Worcester Foundation For Biomedical Research Conjugates of minor groove DNA binders with antisense oligonucleotides
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5846729A (en) 1997-02-27 1998-12-08 Lorne Park Research, Inc. Assaying nucleotides in solution using a fluorescent intensity quenching effect
DE19720839B4 (de) 1997-05-17 2007-08-16 Dirk Dr. Schindelhauer Baukastenprinzip-Technologie zur Herstellung von langen, exakten DNA-Konstrukten in vitro, insbesondere für die Herstellung von Konstrukten zur Erzeugung von künstlichen Chromosomen (MAC, mammalian artificial chromosome) aus zwei stabil klonierten DNA-Komponenten und der ditelomerische Vektor-Prototyp PTAT
DE69836092T2 (de) * 1997-10-24 2007-05-10 Invitrogen Corp., Carlsbad Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
JP4206154B2 (ja) 1997-11-13 2009-01-07 大日本住友製薬株式会社 変異型ｌｏｘＰ配列とその応用
US5989823A (en) * 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
ES2290979T3 (es) 1997-12-15 2008-02-16 Csl Behring Gmbh Cebador marcado para uso en la deteccion de acidos nucleicos diana.
US6127121A (en) 1998-04-03 2000-10-03 Epoch Pharmaceuticals, Inc. Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
US6683173B2 (en) * 1998-04-03 2004-01-27 Epoch Biosciences, Inc. Tm leveling methods
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6072046A (en) * 1998-08-26 2000-06-06 Epoch Pharmaceuticals, Inc. Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide conjugates and reagents for making the same
US6432642B1 (en) 1999-01-15 2002-08-13 Pe Corporation (Ny) Binary probe and clamp composition and methods for a target hybridization detection
DE60042969D1 (de) 1999-03-02 2009-10-29 Life Technologies Corp Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
AU5733900A (en) 1999-06-09 2000-12-28 Biosearch Technologies, Inc. Fluorescence energy transfer probes with stabilized conformations
US6660845B1 (en) * 1999-11-23 2003-12-09 Epoch Biosciences, Inc. Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
US20040081959A9 (en) 1999-12-08 2004-04-29 Epoch Biosciences, Inc. Fluorescent quenching detection reagents and methods
US6727356B1 (en) * 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
ATE391789T1 (de) * 1999-12-10 2008-04-15 Invitrogen Corp Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
EP1995330A1 (de) 2000-03-01 2008-11-26 Epoch Biosciences, Inc. Modifizierte Oligonukleotide zur Erkennung von Fehlanpassungen
EP1294899B3 (de) * 2000-03-31 2011-07-06 Millennium Pharmaceuticals, Inc. 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
US7019129B1 (en) * 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
EP1275735A1 (de) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Zusammensetzung und Methode zur 'Hot start' Nukleinsäureamplifizierung
DK1421200T3 (da) * 2001-08-23 2007-04-10 Merck & Co Inc Fluoprescerende multiplex HPV PCR-assays under anvendelse af flere fluoroforer
WO2003043402A2 (en) 2001-10-19 2003-05-30 Proligo Llc Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
JP4481656B2 (ja) * 2002-02-27 2010-06-16 ライフ テクノロジーズ コーポレーション ３’→５’エキソヌクレアーゼ耐性クエンチャードメインを含むｆｅｔ標識オリゴヌクレオチドを使用する方法およびそれを実施するための組成物
US6818420B2 (en) * 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same

Also Published As

Publication number Publication date
US20090081676A1 (en) 2009-03-26
EP1952792B1 (de) 2010-04-21
US8822673B2 (en) 2014-09-02
US20030165920A1 (en) 2003-09-04
US7160997B2 (en) 2007-01-09
DE60332292D1 (de) 2010-06-02
US20110020812A1 (en) 2011-01-27
US20150072342A1 (en) 2015-03-12
US8088583B2 (en) 2012-01-03
US20030162184A1 (en) 2003-08-28
US6818420B2 (en) 2004-11-16
US7754453B2 (en) 2010-07-13
US20120245334A1 (en) 2012-09-27
ATE464874T1 (de) 2010-05-15
DE60336639D1 (de) 2011-05-19
EP1952792A1 (de) 2008-08-06
EP1952792B2 (de) 2019-01-16
US20170029874A1 (en) 2017-02-02
US9410187B2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
DE60336639D1 (de) Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease-resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens
ATE328115T1 (de) Multiplex genotypisierung unter verwendung von fluoreszenzmarkierten hybridisierungssonden
DE69729122D1 (de) KüNSTLICHE FEHLHYBRIDISIERUNG
DE69637086D1 (de) Verfahren zum nachweis von mehrfachkopien einer wiederholungssequenz in einem nukleinsäuremolekül
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
ATE364718T1 (de) Verfahren zur vervielfältigung von nukleinsäure
ATE211769T1 (de) Oligonukleotide und verfahren zum nachweis von chlamydia trachomatis
ATE414096T1 (de) Verfahren zum nachweis und zur quantifizierung von analyten in komplexen mischungen
BR0308134A (pt) análise rápida das variações em um genoma
EP1468114A4 (de) Late-pcr
WO2005089508A3 (en) Dna sequence detection by limited primer extension
WO2003072051A3 (en) Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same
ATE288964T1 (de) Methoden für externe kontrollen zur nukleinsäure amplifizierung
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
DE502004004202D1 (de) Verfahren zum nachweis von cytosin-methylierungen in dna
ATE534749T1 (de) Sonde und primer zum nachweis von tuberkelbazillen sowie verfahren zum nachweis von tuberkelbazillen beim menschen damit
ATE160822T1 (de) Identifizierung von salmonella durch die polymerase-ketten-reaktion
ATE388245T1 (de) Fluorometrisches verfahren zur überwachung und zum nachweis von nukleinsäure- amplifizierung
DE69616102D1 (de) Amplikationsprimern und Nukleinsäuresonden zum Nachweis von Coccidioides immites
ATE440152T1 (de) Verfahren zum nachweis von cytosinmethylierungsmustern mit hoher empfindlichkeit
ATE414788T1 (de) Verfahren und kit zur tierartspezifischen dna- identifikation in einer probe
ATE315103T1 (de) Verfahren zur typisierung des ha-1 nebenhistokompatibilitätsantigens
ATE307906T1 (de) Verfahren zum nachweis von gram-positiven bakterien
ATE414178T1 (de) Verfahren zum nachweis von polynukleotidsequenzen
MICHELETTI et al. MOCELULAR CHARACTERISATION OF THE NUCLEIC ACIDS RECOVERED FROM AGED FORENSIC SAMPLES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties